|
|
Office Locations:
|
4801 S. Broad St., Suite 340
Philadelphia, PA 19112
Phone: 215-972-1502
| |
|
|
|
|
|
|
Business Services
Financial Services
Information Technology
Life Sciences & Healthcare
Medical Device
|
|
|
|
Rittenhouse Ventures, formerly known as Emerald Stage2 Ventures, is a Philadelphia-based early stage venture fund that invests in emerging technology companies across Pennsylvania and the Mid-Atlantic region with $40 million AUM. The firm invests in small (generally $1 to $3 million) financing rounds of early stage information technology companies that utilize emerging technologies to create compelling business opportunities. While the Fund invests across the information technology spectrum, its primary focus is on companies in the Technology-Enabled Services area. The fund's verticals of interest include Healthcare Information Technology, Pharmaceutical Information Technology, Outsourced Business Services, and Financial Services Information Technology.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
